{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:09Z","timestamp":1792162149129,"version":"4.4.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12872-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:21:18Z","timestamp":1792160478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanisms of cardioprotection: biomarkers, signaling pathways, and emerging molecular signatures in cardiovascular disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Minahil","family":"Amir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laveeza","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ammad","family":"Khursheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taseer","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"25","key":"12872_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA et al (2020) Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982\u20133021","journal-title":"J Am Coll Cardiol"},{"key":"12872_CR2","doi-asserted-by":"publisher","unstructured":"Adhikary D, Barman S, Ranjan R, Stone H A Systematic Review of Major Cardiovascular Risk Factors: A Growing Global Health Concern. Cureus, 14(10):e301190. https:\/\/doi.org\/10.7759\/cureus.30119","DOI":"10.7759\/cureus.30119"},{"key":"12872_CR3","unstructured":"I. of M. (US) C. on a N. S. S. for C. and S. C. Diseases (2011) Cardiovascular Disease, in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases, National Academies Press (US), Accessed: Aug. 23, 2025. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83160\/"},{"issue":"10","key":"12872_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/cells12101432","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023) Pharmacological cardioprotection against ischemia reperfusion injury\u2014the search for a clinical effective therapy. Cells 12(10):1432","journal-title":"Cells"},{"issue":"1","key":"12872_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40256-023-00614-4","volume":"24","author":"H Zhang","year":"2024","unstructured":"Zhang H, Hu H, Zhai C, Jing L, Tian H (2024) Cardioprotective Strategies After Ischemia\u2013Reperfusion Injury. Am J Cardiovasc Drugs 24(1):5\u201318","journal-title":"Am J Cardiovasc Drugs"},{"key":"12872_CR6","doi-asserted-by":"publisher","unstructured":"Fallahi AA, Shekarforoush S (2025) Exercise Training and Cardioprotection in Cardiovascular Disease: A Review of Mechanisms, OBM Integrative and Complementary Medicine 10(3):1\u20139. https:\/\/doi.org\/10.21926\/obm.icm.2503034","DOI":"10.21926\/obm.icm.2503034"},{"issue":"1008","key":"12872_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/pgmj.2008.073759","volume":"85","author":"VO Puntmann","year":"2009","unstructured":"Puntmann VO (2009) How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J 85(1008):538\u2013545","journal-title":"Postgrad Med J"},{"key":"12872_CR8","doi-asserted-by":"publisher","first-page":"8208609","DOI":"10.1155\/2017\/8208609","volume":"2017","author":"Y Huang","year":"2017","unstructured":"Huang Y, Gulshan K, Nguyen T, Wu Y (2017) Biomarkers of Cardiovascular Disease. Dis Markers 2017:8208609. https:\/\/doi.org\/10.1155\/2017\/8208609","journal-title":"Dis Markers"},{"key":"12872_CR9","doi-asserted-by":"publisher","unstructured":"Satoh K, Shimokawa H (May 2018) Recent Advances in the Development of Cardiovascular Biomarkers. ATVB 38(5). https:\/\/doi.org\/10.1161\/ATVBAHA.118.310226","DOI":"10.1161\/ATVBAHA.118.310226"},{"key":"12872_CR10","first-page":"95","volume":"1","author":"SN Fathima","year":"2021","unstructured":"Fathima SN (2021) An update on myocardial infarction. Curr Res Trends Med Sci Technol 1:95","journal-title":"Curr Res Trends Med Sci Technol"},{"issue":"2","key":"12872_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5603\/CJ.a2021.0036","volume":"28","author":"J Domienik-Kar\u0142owicz","year":"2021","unstructured":"Domienik-Kar\u0142owicz J et al (2021) Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome. Cardiol J 28(2):195\u2013201","journal-title":"Cardiol J"},{"issue":"38","key":"12872_CR12","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1093\/eurheartj\/ehaf390","volume":"46","author":"NS Nurmohamed","year":"2025","unstructured":"Nurmohamed NS et al (2025) First myocardial infarction: risk factors, symptoms, and medical therapy. Eur Heart J 46(38):3762\u20133772","journal-title":"Eur Heart J"},{"issue":"6","key":"12872_CR13","first-page":"511","volume":"12","author":"V Katari","year":"2023","unstructured":"Katari V, Kanajam LS, Kokkiligadda S, Sharon T, Kantamaneni P (2023) A review on causes of myocardial infarction and its management. World J Pharm Res 12(6):511\u2013529","journal-title":"World J Pharm Res"},{"key":"12872_CR14","doi-asserted-by":"publisher","unstructured":"Zhang M et al (Jan. 2024) Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Sig Transduct Target Ther 9(1). https:\/\/doi.org\/10.1038\/s41392-023-01688-x","DOI":"10.1038\/s41392-023-01688-x"},{"key":"12872_CR15","doi-asserted-by":"publisher","unstructured":"He J et al (Jun. 2022) Myocardial ischemia\/reperfusion injury: Mechanisms of injury and implications for management (Review). Exp Ther Med 23(6):430. https:\/\/doi.org\/10.3892\/etm.2022.11357","DOI":"10.3892\/etm.2022.11357"},{"key":"12872_CR16","doi-asserted-by":"publisher","first-page":"1679085","DOI":"10.3389\/fphar.2025.1679085","volume":"16","author":"M Wang","year":"2025","unstructured":"Wang M, Zhu Z, He X, Dai S, Liu R, Liu J (2025) The crosstalk between mitochondrial dysfunction and fatty acid metabolism in heart failure: mechanisms and therapeutic strategies. Front Pharmacol 16:1679085","journal-title":"Front Pharmacol"},{"key":"12872_CR17","doi-asserted-by":"publisher","unstructured":"Thupakula S, Nimmala SSR, Ravula H, Chekuri S, Padiya R (Oct. 2022) Emerging biomarkers for the detection of cardiovascular diseases. Egypt Heart J 74(1):77. https:\/\/doi.org\/10.1186\/s43044-022-00317-2","DOI":"10.1186\/s43044-022-00317-2"},{"key":"12872_CR18","doi-asserted-by":"crossref","unstructured":"Alzaabi MA et al (2024) Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review, Mar. Accessed: Aug. 22, 2025. [Online]. Available: https:\/\/www.cfrjournal.com\/articles\/evaluating-biomarkers-tools-early-detection-and-prognosis-heart-failure-comprehensive?language_content_entity=en","DOI":"10.15420\/cfr.2023.24"},{"key":"12872_CR19","doi-asserted-by":"publisher","unstructured":"Kayani M et al Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review. Cureus 16(2):e53445. https:\/\/doi.org\/10.7759\/cureus.53445","DOI":"10.7759\/cureus.53445"},{"issue":"4","key":"12872_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14797\/mdcvj.1381","volume":"20","author":"E Meekers","year":"2024","unstructured":"Meekers E, Dupont M (2024) Role of imaging and biomarkers in identifying, monitoring, and promoting myocardial recovery. Methodist Debakey Cardiovasc J 20(4):42","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"12872_CR21","doi-asserted-by":"publisher","unstructured":"Aleksova A et al (Jan. 2025) Biomarkers of Importance in Monitoring Heart Condition After Acute Myocardial Infarction. J Clin Med 14(1):129. https:\/\/doi.org\/10.3390\/jcm14010129","DOI":"10.3390\/jcm14010129"},{"key":"12872_CR22","doi-asserted-by":"publisher","unstructured":"K\u00fcbler W, Haass M (1996) Cardioprotection: definition, classification, and fundamental principles., Heart 75(4):330\u2013333. https:\/\/doi.org\/10.1136\/hrt.75.4.330","DOI":"10.1136\/hrt.75.4.330"},{"key":"12872_CR23","doi-asserted-by":"publisher","unstructured":"Bulluck H, Hausenloy DJ (Jul. 2015) Ischaemic conditioning: are we there yet? Heart 101(13):1067\u20131077. https:\/\/doi.org\/10.1136\/heartjnl-2014-306531","DOI":"10.1136\/heartjnl-2014-306531"},{"key":"12872_CR24","doi-asserted-by":"publisher","unstructured":"Rosenberg JH, Werner JH, Moulton MJ, Agrawal DK (Aug. 2018) Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning. J Cardiovasc Trans Res 11(4):292\u2013307. https:\/\/doi.org\/10.1007\/s12265-018-9813-1","DOI":"10.1007\/s12265-018-9813-1"},{"key":"12872_CR25","doi-asserted-by":"publisher","unstructured":"Comit\u00e0 S, Rubeo C, Giordano M, Penna C, Pagliaro P (2023) Pathways for Cardioprotection in Perspective: Focus on Remote Conditioning and Extracellular Vesicles, Biology 12(2):308. https:\/\/doi.org\/10.3390\/biology12020308","DOI":"10.3390\/biology12020308"},{"key":"12872_CR26","unstructured":"Hausenloy DJ Cardioprotection Techniques: Preconditioning, Postconditioning and Remote Con-ditioning (Basic Science). http:\/\/www.eurekaselect.com, Accessed: Aug. 25, 2025. [Online]. Available: https:\/\/www.eurekaselect.com\/article\/52968"},{"issue":"9861","key":"12872_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","volume":"381","author":"G Heusch","year":"2013","unstructured":"Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381(9861):166\u2013175","journal-title":"Lancet"},{"key":"12872_CR28","doi-asserted-by":"publisher","unstructured":"Hausenloy DJ et al (Oct. 2019) Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial. Lancet 394(10207):1415\u20131424. https:\/\/doi.org\/10.1016\/S0140-6736(19)32039-2","DOI":"10.1016\/S0140-6736(19)32039-2"},{"key":"12872_CR29","doi-asserted-by":"publisher","unstructured":"Meybohm P A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery | New England Journal of Medicine. Accessed: Aug. 28, 2026. [Online]. Available: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa1413579","DOI":"10.1056\/NEJMoa1413579"},{"key":"12872_CR30","doi-asserted-by":"publisher","unstructured":"Marzetti E, Wohlgemuth SE, Anton SD, Bernabei R, Carter CS, Leeuwenburgh C (2009) Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives, Clin Geriatr Med 25(4):715\u2013732. https:\/\/doi.org\/10.1016\/j.cger.2009.07.002","DOI":"10.1016\/j.cger.2009.07.002"},{"issue":"14","key":"12872_CR31","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.scib.2025.05.017","volume":"70","author":"J Zhang","year":"2025","unstructured":"Zhang J et al (2025) Intermittent fasting and cardiovascular health: a circadian rhythm-based approach. Sci Bull 70(14):2377\u20132389","journal-title":"Sci Bull"},{"key":"12872_CR32","doi-asserted-by":"publisher","unstructured":"Penna C, Alloatti G, Crisafulli A (2020) Mechanisms Involved in Cardioprotection Induced by Physical Exercise. https:\/\/home.liebertpub.com\/ ars, Apr. https:\/\/doi.org\/10.1089\/ars.2019.8009","DOI":"10.1089\/ars.2019.8009"},{"key":"12872_CR33","doi-asserted-by":"publisher","unstructured":"Quindry JC, Franklin BA (Jun. 2021) Exercise Preconditioning as a Cardioprotective Phenotype. Am J Cardiol 148:8\u201315. https:\/\/doi.org\/10.1016\/j.amjcard.2021.02.030","DOI":"10.1016\/j.amjcard.2021.02.030"},{"key":"12872_CR34","doi-asserted-by":"publisher","unstructured":"Marongiu E, Crisafulli A (2014) Cardioprotection Acquired Through Exercise: The Role of Ischemic Preconditioning, Curr Cardiol Rev 10(4):336\u2013348. https:\/\/doi.org\/10.2174\/1573403X10666140404110229","DOI":"10.2174\/1573403X10666140404110229"},{"key":"12872_CR35","doi-asserted-by":"publisher","unstructured":"Niemann B et al (1931) Caloric restriction reduces sympathetic activity similar to beta-blockers but conveys additional mitochondrio-protective effects in aged myocardium, Sci Rep, vol. 11, p. Jan. 2021. https:\/\/doi.org\/10.1038\/s41598-021-81438-7","DOI":"10.1038\/s41598-021-81438-7"},{"key":"12872_CR36","doi-asserted-by":"publisher","unstructured":"Pamplona R, Portero-Ot\u00edn M, Requena J, Gredilla R, Barja G (2002) Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls, Mech Ageing Dev 123(11):1437\u20131446. https:\/\/doi.org\/10.1016\/s0047-6374(02)00076-3","DOI":"10.1016\/s0047-6374(02)00076-3"},{"issue":"6","key":"12872_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.orcp.2023.11.006","volume":"17","author":"Z Hajializadeh","year":"2023","unstructured":"Hajializadeh Z, Khaksari M (2023) Cardioprotective effects of calorie restriction against inflammation and apoptosis in ovariectomized obese rats: Role of classical estrogen receptors and SIRT1. Obes Res Clin Pract 17(6):492\u2013498. https:\/\/doi.org\/10.1016\/j.orcp.2023.11.006","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"12872_CR38","doi-asserted-by":"publisher","first-page":"e0130658","DOI":"10.1371\/journal.pone.0130658","volume":"10","author":"H Noyan","year":"2015","unstructured":"Noyan H et al (2015) Cardioprotective Signature of Short-Term Caloric Restriction. PLoS ONE 10(6):e0130658. https:\/\/doi.org\/10.1371\/journal.pone.0130658","journal-title":"PLoS ONE"},{"key":"12872_CR39","doi-asserted-by":"publisher","unstructured":"Chandrasekar B, Nelson JF, Colston JT, Freeman GL (May 2001) Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 280 5, pp. H2094-2102. https:\/\/doi.org\/10.1152\/ajpheart.2001.280.5.H2094","DOI":"10.1152\/ajpheart.2001.280.5.H2094"},{"key":"12872_CR40","doi-asserted-by":"publisher","unstructured":"Wohlgemuth SE et al (2007) Sep., Autophagy in the heart and liver during normal aging and calorie restriction, Rejuvenation Res 10(3):281\u2013292. https:\/\/doi.org\/10.1089\/rej.2006.0535","DOI":"10.1089\/rej.2006.0535"},{"key":"12872_CR41","doi-asserted-by":"publisher","unstructured":"Hausenloy DJ, Yellon DM (Feb. 2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61(3):448\u2013460. https:\/\/doi.org\/10.1016\/j.cardiores.2003.09.024","DOI":"10.1016\/j.cardiores.2003.09.024"},{"key":"12872_CR42","doi-asserted-by":"publisher","unstructured":"Ping P, Zhang J, Pierce WM, Bolli R (Jan. 2001) Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 88(1):59\u201362. https:\/\/doi.org\/10.1161\/01.res.88.1.59","DOI":"10.1161\/01.res.88.1.59"},{"key":"12872_CR43","doi-asserted-by":"publisher","unstructured":"Lecour S (Jul. 2009) Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol 47(1):32\u201340. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.03.019","DOI":"10.1016\/j.yjmcc.2009.03.019"},{"key":"12872_CR44","doi-asserted-by":"publisher","unstructured":"Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning, Pharmacol Rev, vol. 59, no. 4, pp. 418\u2013458, Dec. https:\/\/doi.org\/10.1124\/pr.107.06002","DOI":"10.1124\/pr.107.06002"},{"key":"12872_CR45","unstructured":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale - PubMed. Accessed: Jul. 26, 2026. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/20959622\/"},{"key":"12872_CR46","doi-asserted-by":"publisher","unstructured":"Yao H, Han X, Han X (Dec. 2014) The Cardioprotection of the Insulin-Mediated PI3K\/Akt\/mTOR Signaling Pathway. Am J Cardiovasc Drugs 14(6):433\u2013442. https:\/\/doi.org\/10.1007\/s40256-014-0089-9","DOI":"10.1007\/s40256-014-0089-9"},{"key":"12872_CR47","doi-asserted-by":"publisher","unstructured":"Ghafouri-Fard S et al (2022) Interplay between PI3K\/AKT pathway and heart disorders, Mol Biol Rep 49(10):9767\u20139781. https:\/\/doi.org\/10.1007\/s11033-022-07468-0","DOI":"10.1007\/s11033-022-07468-0"},{"issue":"10","key":"12872_CR48","doi-asserted-by":"publisher","first-page":"e76659","DOI":"10.1371\/journal.pone.0076659","volume":"8","author":"G Milano","year":"2013","unstructured":"Milano G et al (2013) Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia. PLoS ONE 8(10):e76659","journal-title":"PLoS ONE"},{"issue":"9","key":"12872_CR49","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/cells11091553","volume":"11","author":"B Walkowski","year":"2022","unstructured":"Walkowski B, Kleibert M, Majka M, Wojciechowska M (2022) Insight into the role of the PI3K\/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart. Cells 11(9):1553","journal-title":"Cells"},{"key":"12872_CR50","doi-asserted-by":"publisher","unstructured":"Deng R, Zhou J (Oct. 2023) The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury. Int Immunopharmacol 123:110714. https:\/\/doi.org\/10.1016\/j.intimp.2023.110714","DOI":"10.1016\/j.intimp.2023.110714"},{"key":"12872_CR51","doi-asserted-by":"crossref","unstructured":"Jiang C, Xie N, Sun T, Ma W, Zhang B, Li W (2020) Xanthohumol inhibits TGF-\u03b21-induced cardiac fibroblasts activation via mediating PTEN\/Akt\/mTOR signaling pathway, Drug Design, Development and Therapy, pp. 5431\u20135439","DOI":"10.2147\/DDDT.S282206"},{"issue":"11","key":"12872_CR52","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(11):1121\u20131135","journal-title":"N Engl J Med"},{"key":"12872_CR53","doi-asserted-by":"crossref","unstructured":"Murriel CL, Mochly-Rosen D (2003) Opposing roles of \u03b4 and \u03b5PKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery, Archives of biochemistry and biophysics 420(2):246\u2013254","DOI":"10.1016\/j.abb.2003.08.038"},{"issue":"4","key":"12872_CR54","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90(4):1507\u20131546","journal-title":"Physiol Rev"},{"issue":"5","key":"12872_CR55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.yjmcc.2009.01.010","volume":"46","author":"CJ Peters","year":"2009","unstructured":"Peters CJ et al (2009) In situ co-distribution and functional interactions of SAP97 with sinoatrial isoforms of HCN channels. J Mol Cell Cardiol 46(5):636\u2013643","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"12872_CR56","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/pr.107.06002","volume":"59","author":"P Ferdinandy","year":"2007","unstructured":"Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59(4):418\u2013458","journal-title":"Pharmacol Rev"},{"issue":"2","key":"12872_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00395-018-0670-5","volume":"113","author":"N Hadebe","year":"2018","unstructured":"Hadebe N, Cour M, Lecour S (2018) The SAFE pathway for cardioprotection: is this a promising target? Basic Res Cardiol 113(2):9","journal-title":"Basic Res Cardiol"},{"key":"12872_CR58","doi-asserted-by":"publisher","unstructured":"Zhang H, Hu H, Zhai C, Jing L, Tian H (Jan. 2024) Cardioprotective Strategies After Ischemia\u2013Reperfusion Injury. Am J Cardiovasc Drugs 24(1):5\u201318. https:\/\/doi.org\/10.1007\/s40256-023-00614-4","DOI":"10.1007\/s40256-023-00614-4"},{"issue":"7","key":"12872_CR59","first-page":"341","volume":"1","author":"\u0422\u0418 \u0411\u0430\u0440\u0430\u043d\u0438\u0447","year":"2018","unstructured":"\u0411\u0430\u0440\u0430\u043d\u0438\u0447 \u0422\u0418, \u0421\u0443\u0445\u043e\u0440\u0443\u043a\u043e\u0432 \u0412\u0421, \u0413\u043b\u0438\u043d\u043a\u0438\u043d\u0430 \u0412\u0412, \u0410\u0442\u043e\u0447\u0438\u043d \u0414\u041d (2018) RISK, SAFE, and eNOS pathways in conditioning cardiac protection. Conditioning Med 1(7):341\u2013343","journal-title":"Conditioning Med"},{"key":"12872_CR60","doi-asserted-by":"publisher","first-page":"108801","DOI":"10.1016\/j.pharmthera.2025.108801","volume":"267","author":"Z Wang","year":"2025","unstructured":"Wang Z et al (2025) From physiology to pathology: Emerging roles of GPER in cardiovascular disease. Pharmacology Therapeutics 267:108801","journal-title":"Pharmacology Therapeutics"},{"key":"12872_CR61","doi-asserted-by":"publisher","unstructured":"Budas GR, Churchill EN, Mochly-Rosen D (2007) Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury, Pharmacol Res 55(6):523\u2013536. https:\/\/doi.org\/10.1016\/j.phrs.2007.04.005","DOI":"10.1016\/j.phrs.2007.04.005"},{"key":"12872_CR62","doi-asserted-by":"publisher","unstructured":"Heusch G (Dec. 2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17(12):773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","DOI":"10.1038\/s41569-020-0403-y"},{"key":"12872_CR63","doi-asserted-by":"publisher","unstructured":"Caccioppo A, Franchin L, Grosso A, Angelini F, D\u2019Ascenzo F, Brizzi MF (Oct. 2019) Ischemia Reperfusion Injury: Mechanisms of Damage\/Protection and Novel Strategies for Cardiac Recovery\/Regeneration. Int J Mol Sci 20(20):5024. https:\/\/doi.org\/10.3390\/ijms20205024","DOI":"10.3390\/ijms20205024"},{"key":"12872_CR64","doi-asserted-by":"publisher","unstructured":"Murphy E, Steenbergen C (Apr. 2008) Mechanisms Underlying Acute Protection from Cardiac Ischemia-Reperfusion Injury. Physiol Rev 88(2):581. https:\/\/doi.org\/10.1152\/physrev.00024.2007","DOI":"10.1152\/physrev.00024.2007"},{"issue":"4","key":"12872_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00395-018-0679-9","volume":"113","author":"M Park","year":"2018","unstructured":"Park M, Sandner P, Krieg T (2018) cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway. Basic Res Cardiol 113(4):24","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"12872_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","volume":"73","author":"SM Davidson","year":"2019","unstructured":"Davidson SM et al (2019) Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol 73(1):89\u201399","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"12872_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.gene.2016.06.016","volume":"590","author":"SB Scruggs","year":"2016","unstructured":"Scruggs SB, Wang D, Ping P (2016) PRKCE gene encoding protein kinase C-epsilon\u2014dual roles at sarcomeres and mitochondria in cardiomyocytes. Gene 590(1):90\u201396","journal-title":"Gene"},{"key":"12872_CR68","doi-asserted-by":"publisher","unstructured":"Rose BA, Force T, Wang Y (2010) Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale, Physiological Reviews, vol. 90, no. 4, pp. 1507\u20131546, Oct. https:\/\/doi.org\/10.1152\/physrev.00054.2009","DOI":"10.1152\/physrev.00054.2009"},{"key":"12872_CR69","doi-asserted-by":"publisher","unstructured":"Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection, Heart Fail Rev, vol. 12, no. 3, pp. 217\u2013234, Dec. https:\/\/doi.org\/10.1007\/s10741-007-9026-1","DOI":"10.1007\/s10741-007-9026-1"},{"key":"12872_CR70","doi-asserted-by":"publisher","unstructured":"Pohjoism\u00e4ki JL, Goffart S (May 2017) The role of mitochondria in cardiac development and protection. Free Radic Biol Med 106:345\u2013354. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.02.032","DOI":"10.1016\/j.freeradbiomed.2017.02.032"},{"key":"12872_CR71","doi-asserted-by":"publisher","unstructured":"Garlid KD, Costa ADT, Quinlan CL, Pierre SV, Santos PD (2009) Cardioprotective Signaling to Mitochondria, J Mol Cell Cardiol 46(6):858\u2013866. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.11.019","DOI":"10.1016\/j.yjmcc.2008.11.019"},{"key":"12872_CR72","doi-asserted-by":"publisher","unstructured":"Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, Lin Y-H, Hausenloy DJ (Jul. 2020) Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine 57:102884. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102884","DOI":"10.1016\/j.ebiom.2020.102884"},{"key":"12872_CR73","doi-asserted-by":"publisher","unstructured":"Perrelli M-G, Pagliaro P, Penna C (Jun. 2011) Ischemia\/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J Cardiol 3(6):186\u2013200. https:\/\/doi.org\/10.4330\/wjc.v3.i6.186","DOI":"10.4330\/wjc.v3.i6.186"},{"key":"12872_CR74","doi-asserted-by":"publisher","unstructured":"D\u2019Oria R et al (2020) The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor, Oxid Med Cell Longev, vol. p. 5732956, May 2020. https:\/\/doi.org\/10.1155\/2020\/5732956","DOI":"10.1155\/2020\/5732956"},{"issue":"3","key":"12872_CR75","first-page":"206","volume":"11","author":"S Vasdev","year":"2006","unstructured":"Vasdev S, Gill VD, Singal PK (2006) Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants. Exp Clin Cardiol 11(3):206\u2013216","journal-title":"Exp Clin Cardiol"},{"key":"12872_CR76","doi-asserted-by":"publisher","unstructured":"Ong S-B et al (Jun. 2018) Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacology Therapeutics 186:73\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001","DOI":"10.1016\/j.pharmthera.2018.01.001"},{"issue":"6","key":"12872_CR77","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2010.3587","volume":"14","author":"NS Rajasekaran","year":"2011","unstructured":"Rajasekaran NS et al (2011) Sustained activation of nuclear erythroid 2-related factor 2\/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxidants redox signaling 14(6):957\u2013971","journal-title":"Antioxidants redox signaling"},{"issue":"5","key":"12872_CR78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","volume":"20","author":"S Wei","year":"2020","unstructured":"Wei S et al (2020) Involvement of ROS\/NLRP3 inflammasome signaling pathway in doxorubicin-induced cardiotoxicity. Cardiovasc Toxicol 20(5):507\u2013519","journal-title":"Cardiovasc Toxicol"},{"key":"12872_CR79","doi-asserted-by":"publisher","unstructured":"Schirone L et al (2022) An Overview of the Molecular Mechanisms Associated with Myocardial Ischemic Injury: State of the Art and Translational Perspectives, Cells 11(7):1165. https:\/\/doi.org\/10.3390\/cells11071165","DOI":"10.3390\/cells11071165"},{"key":"12872_CR80","doi-asserted-by":"publisher","unstructured":"Heusch G (May 2016) The Coronary Circulation as a Target of Cardioprotection. Circul Res 118(10):1643\u20131658. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308640","DOI":"10.1161\/CIRCRESAHA.116.308640"},{"key":"12872_CR81","doi-asserted-by":"publisher","unstructured":"Fang J et al (2011) Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats, Journal of Molecular and Cellular Cardiology, 51(5), 839\u2013847. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.06.013","DOI":"10.1016\/j.yjmcc.2011.06.013"},{"key":"12872_CR82","doi-asserted-by":"publisher","unstructured":"Dhingra R, Vasan RS (2016) Biomarkers in Cardiovascular Disease: Statistical Assessment and Section on Key Novel Heart Failure Biomarkers, Trends in cardiovascular medicine 27(2):123. https:\/\/doi.org\/10.1016\/j.tcm.2016.07.005","DOI":"10.1016\/j.tcm.2016.07.005"},{"key":"12872_CR83","doi-asserted-by":"publisher","unstructured":"Rajappa M, Sharma A (2005) Biomarkers of Cardiac Injury: An Update, Angiology 56(6):677\u2013691. https:\/\/doi.org\/10.1177\/000331970505600605","DOI":"10.1177\/000331970505600605"},{"issue":"10","key":"12872_CR84","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3390\/ijms23105680","volume":"23","author":"F Omran","year":"2022","unstructured":"Omran F, Kyrou I, Osman F, Lim VG, Randeva HS, Chatha K (2022) Cardiovascular biomarkers: lessons of the past and prospects for the future. Int J Mol Sci 23(10):5680","journal-title":"Int J Mol Sci"},{"key":"12872_CR85","doi-asserted-by":"publisher","unstructured":"Krylatov AV et al (2021) The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia\/Reperfusion and Postinfarction Heart Remodeling, J Cardiovasc Pharmacol Ther 26(2):131\u2013148. https:\/\/doi.org\/10.1177\/1074248420952243","DOI":"10.1177\/1074248420952243"},{"key":"12872_CR86","doi-asserted-by":"publisher","unstructured":"Boerrigter G, Costello-Boerrigter LC, Burnett JC (Oct. 2009) Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure. Heart Fail Clin 5(4):501\u2013514. https:\/\/doi.org\/10.1016\/j.hfc.2009.04.002","DOI":"10.1016\/j.hfc.2009.04.002"},{"key":"12872_CR87","doi-asserted-by":"publisher","unstructured":"Weber M, Hamm C (2006) Role of B-type natriuretic peptide (BNP) and NT\u2010proBNP in clinical routine, Heart 92(6):843\u2013849. https:\/\/doi.org\/10.1136\/hrt.2005.071233","DOI":"10.1136\/hrt.2005.071233"},{"key":"12872_CR88","doi-asserted-by":"publisher","unstructured":"Felker GM, Petersen JW, Mark DB (2006) Natriuretic peptides in the diagnosis and management of heart failure, CMAJ 175(6):611\u2013617. https:\/\/doi.org\/10.1503\/cmaj.060236","DOI":"10.1503\/cmaj.060236"},{"key":"12872_CR89","first-page":"1","volume":"40","author":"O Vuolteenaho","year":"2005","unstructured":"Vuolteenaho O, Ala-Kopsala M, Ruskoaho H (2005) BNP as a biomarker in heart disease. Adv Clin Chem 40:1\u201336","journal-title":"Adv Clin Chem"},{"key":"12872_CR90","doi-asserted-by":"publisher","unstructured":"Ding K, Gui Y, Hou X, Ye L, Wang L (May 2022) Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure. Front Cardiovasc Med 9:904881. https:\/\/doi.org\/10.3389\/fcvm.2022.904881","DOI":"10.3389\/fcvm.2022.904881"},{"key":"12872_CR91","doi-asserted-by":"crossref","unstructured":"Al-Hadi HA, Fox KA (2009) Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome, Sultan Qaboos Univ Med J 9(3):231\u2013246","DOI":"10.18295\/2075-0528.2796"},{"key":"12872_CR92","doi-asserted-by":"publisher","unstructured":"Singh V, Martinezclark P, Pascual M, Shaw ES, O\u2019Neill WW (2010) Cardiac biomarkers \u2013 the old and the new: a review, Coronary Artery Disease 21(4):244\u2013256. https:\/\/doi.org\/10.1097\/MCA.0b013e328338cd1f","DOI":"10.1097\/MCA.0b013e328338cd1f"},{"key":"12872_CR93","unstructured":"Kurapati R, Zubair M, Creatine Kinase MB Diagnostic Utility and Limitations, in StatPearls, Treasure Island (FL): StatPearls Publishing, 2026. Accessed: Aug. 30, 2026. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557591\/"},{"issue":"1","key":"12872_CR94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0736-4679(98)00129-2","volume":"17","author":"DJ Robinson","year":"1999","unstructured":"Robinson DJ, Christenson RH (1999) Creatine kinase and its CK-MB isoenzyme: the conventional marker for the diagnosis of acute myocardial infarction. J Emerg Med 17(1):95\u2013104. https:\/\/doi.org\/10.1016\/s0736-4679(98)00129-2","journal-title":"J Emerg Med"},{"key":"12872_CR95","doi-asserted-by":"publisher","unstructured":"Janjusevic M et al (Jan. 2021) Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction\u2014Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage. Int J Mol Sci 22(9):4937. https:\/\/doi.org\/10.3390\/ijms22094937","DOI":"10.3390\/ijms22094937"},{"key":"12872_CR96","doi-asserted-by":"publisher","unstructured":"Thygesen K et al (Oct. 2018) Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 72(18):2231\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038","DOI":"10.1016\/j.jacc.2018.08.1038"},{"issue":"5","key":"12872_CR97","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ejhf.2848","volume":"25","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H et al (2023) Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail 25(5):616\u2013631","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"12872_CR98","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA et al (2023) 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 44(37):3627\u20133639","journal-title":"Eur Heart J"},{"key":"12872_CR99","doi-asserted-by":"publisher","unstructured":"Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M (2022) Biomarkers for the diagnosis and management of heart failure, Heart Fail Rev, vol. 27, no. 2, pp. 625\u2013643, Mar. https:\/\/doi.org\/10.1007\/s10741-021-10105-w","DOI":"10.1007\/s10741-021-10105-w"},{"issue":"2","key":"12872_CR100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.15386\/cjmed-751","volume":"90","author":"HZ AMIN","year":"2017","unstructured":"AMIN HZ, AMIN LZ, WIJAYA IP (2017) Galectin-3: a novel biomarker for the prognosis of heart failure. Clujul Med 90(2):129\u2013132. https:\/\/doi.org\/10.15386\/cjmed-751","journal-title":"Clujul Med"},{"issue":"17","key":"12872_CR101","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","volume":"74","author":"A Aimo","year":"2019","unstructured":"Aimo A et al (2019) Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week. J Am Coll Cardiol 74(17):2193\u20132203","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"12872_CR102","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18773\/austprescr.2022.006","volume":"45","author":"JM Potter","year":"2022","unstructured":"Potter JM, Hickman PE, Cullen L (2022) Troponins in myocardial infarction and injury. Australian prescriber 45(2):53","journal-title":"Australian prescriber"},{"key":"12872_CR103","doi-asserted-by":"publisher","unstructured":"Tsutsui H et al (May 2023) Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. J Card Fail 29(5):787\u2013804. https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.009","DOI":"10.1016\/j.cardfail.2023.02.009"},{"issue":"2","key":"12872_CR104","doi-asserted-by":"publisher","first-page":"129","DOI":"10.15386\/cjmed-751","volume":"90","author":"HZ AMIN","year":"2017","unstructured":"AMIN HZ, AMIN LZ, WIJAYA IP (2017) Galectin-3: a novel biomarker for the prognosis of heart failure. Clujul Med 90(2):129\u2013132. https:\/\/doi.org\/10.15386\/cjmed-751","journal-title":"Clujul Med"},{"key":"12872_CR105","doi-asserted-by":"publisher","unstructured":"Meijers WC et al (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC), Eur J Heart Fail 23(10):1610\u20131632. https:\/\/doi.org\/10.1002\/ejhf.2346","DOI":"10.1002\/ejhf.2346"},{"key":"12872_CR106","doi-asserted-by":"publisher","unstructured":"Butler J, Papadimitriou L, Georgiopoulou V, Skopicki H, Dunbar S, Kalogeropoulos A (May 2015) Comparing Sodium Intake Strategies in Heart Failure. Circulation: Heart Fail 8(3):636\u2013645. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001700","DOI":"10.1161\/CIRCHEARTFAILURE.114.001700"},{"issue":"22","key":"12872_CR107","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","volume":"135","author":"SL Chow","year":"2017","unstructured":"Chow SL et al (2017) Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation 135(22):e1054\u2013e1091","journal-title":"Circulation"},{"issue":"6","key":"12872_CR108","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ejhf.273","volume":"17","author":"RA De Boer","year":"2015","unstructured":"De Boer RA, Daniels LB, Maisel AS, Januzzi JL Jr (2015) State of the art: newer biomarkers in heart failure. Eur J Heart Fail 17(6):559\u2013569","journal-title":"Eur J Heart Fail"},{"key":"12872_CR109","doi-asserted-by":"publisher","unstructured":"Makkos A, \u00c1gg B, Petrovich B, Varga ZV, G\u00f6rbe A, Ferdinandy P (2021) Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia\/reperfusion injury and infarction: Involvement of redox signalling, Free Radic Biol Med 172,237\u2013251. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.04.034","DOI":"10.1016\/j.freeradbiomed.2021.04.034"},{"key":"12872_CR110","unstructured":"Molecular signatures and the study of gene expression profiles in inflammatory heart diseases - PubMed. Accessed: Sep. 01, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/22918566\/"},{"key":"12872_CR111","doi-asserted-by":"publisher","unstructured":"Frank D et al (Feb. 2008) Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program. Hypertension 51(2):309\u2013318. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.098046","DOI":"10.1161\/HYPERTENSIONAHA.107.098046"},{"key":"12872_CR112","doi-asserted-by":"publisher","unstructured":"Wilhide ME et al (2011) Identification of a NF-\u03baB cardioprotective gene program: NF-\u03baB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion, J Mol Cell Cardiol 51(1):82\u201389. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.03.011","DOI":"10.1016\/j.yjmcc.2011.03.011"},{"key":"12872_CR113","doi-asserted-by":"publisher","unstructured":"Melo Z, Ishida C, Goldaraz MD, Rojo R, Echavarria R (2018) Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection, Non-Coding RNA, vol. 4, no. 3, p. 22, Sep. https:\/\/doi.org\/10.3390\/ncrna4030022","DOI":"10.3390\/ncrna4030022"},{"issue":"2","key":"12872_CR114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14789450.2018.1421947","volume":"15","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Jung M, Hall ME, DeLeon-Pennell KY (2018) Proteomic analysis of the cardiac extracellular matrix: clinical research applications. Expert Rev Proteomics 15(2):105\u2013112","journal-title":"Expert Rev Proteomics"},{"issue":"8","key":"12872_CR115","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.rec.2013.04.009","volume":"66","author":"J Barallobre-Barreiro","year":"2013","unstructured":"Barallobre-Barreiro J, Chung Y-L, Mayr M (2013) Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 66(8):657\u2013661","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"12872_CR116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","volume":"174","author":"L Barile","year":"2017","unstructured":"Barile L, Vassalli G (2017) Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacology therapeutics 174:63\u201378","journal-title":"Pharmacology therapeutics"},{"issue":"3","key":"12872_CR117","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jacbts.2016.11.010","volume":"2","author":"KW Johnson","year":"2017","unstructured":"Johnson KW et al (2017) Enabling precision cardiology through multiscale biology and systems medicine. Basic Translational Sci 2(3):311\u2013327","journal-title":"Basic Translational Sci"},{"issue":"1","key":"12872_CR118","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18(1):83","journal-title":"Genome Biol"},{"key":"12872_CR119","doi-asserted-by":"crossref","unstructured":"Morrow DA, de Lemos JA (2007) Benchmarks for the assessment of novel cardiovascular biomarkers, vol 115, 8no. edn. Lippincott Williams & Wilkins, pp 949\u2013952","DOI":"10.1161\/CIRCULATIONAHA.106.683110"},{"key":"12872_CR120","doi-asserted-by":"publisher","unstructured":"Mn L, Pl M (Jan. 2019) Novel biomarkers of cardiovascular disease: Applications in clinical practice. Crit Rev Clin Lab Sci 56(1). https:\/\/doi.org\/10.1080\/10408363.2018.1525335","DOI":"10.1080\/10408363.2018.1525335"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12872-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:21:20Z","timestamp":1792160480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12872"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12872-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"1735"}}